Diligence memo · auto-generated · as of July 2, 2026
Treint Investment Inc.
Treint Investment Inc. looks fair against its niche peers and is at-risk on financing cadence.
Businessfiled
Treint Investment Inc. operates in Other Health Care, based in ALMATY.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Treint Investment Inc. has raised $20M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $20M on 2023-09-01.
Most recent recorded round closed around 2023-09-01.
Valuation (modeled)modeled
Provath models Treint Investment Inc. at approximately $169M (range $47M–$356M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.11× the median modeled value of Series B Other Health Care companies in 2022–2024 (91 peers) — value vs value, same stage and era. Within the normal band (111% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 2.8 yr ago; this sector typically re-raises about every 14 months.
Past due for a raise versus sector cadence — watch for distress or a bridge.
Comparablesmixed
Capital scale ranks ahead of 84% of Other Health Care peers (5377 compared).
Modeled value ranks above 86% of those peers.
Closest niche peers: Code Biotherapeutics, Inc., Candesant Biomedical, Inc., Artis Holdings, LLC, GIO Blood Ltd, Clarapath, Inc..
Peoplefiled
1 named person on file across officers, directors and signatories.
Risks & flagsmixed
Overdue for a raise versus sector norm — distress or bridge risk.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.